Our News and Updates
our action against COVID-19
To contribute the fight to tackle coronavirus pandemic, Neuro-Zone started a new development program to repurpose an existing drug potentially able to interfere with COVID-19 cell penetration mechanism.
PROJECT UPDATES- 16 March: Neuro-Zone set up a project summary and filed it to Italian health authorities to evaluate the scientific rational and feasibility.
- 6 April: Neuro-Zone has obtained positive opinion from Italian health authorities to proceed with a formal clinical development program to validate the efficacy of the pharmaceutical candidate in early diagnosed COVID-19 patients.
- 4 May: The team is currently working on:
- CLINICAL OBSERVATIONAL STUDY SET UP: definition of study criteria and methodology to assess the incidence and outcomes severity of COVID-19 infection in patient treated with the identified compound
- CO-DEVELOPMENT: identification of a pharmaceutical partner to start a co-development project
Neuro-Zone will be glad to meet you:
- 26-29 October, at BIO-Europe Digital Event 2020
- 21 October, at China Focus Partnering Conference
- 23-25 March, Paris, France at BIO Europe Spring 2020
- 8-12 June, at BIO Digital 2020
Highlights:
- June 2019: Neuro-Zone and BiomimX entered into a commecial collaboration agreement - Press Release
Neuro-Zone will be glad to meet you:
- 3-6 June, Philadelphia, USA at BIO 2019
- 11-13 November, Hamburg at BIO Europe 2019
Highlights:
- December 2019: Neuro-Zone and Polytechnic University of Milan have been selected as beneficiaries for the ERC-2019-PoC Grant DIANA - Organ-on-a-chip Drug screenIng device to tArget braiN diseAse
- February 2019: Neuro-Zone is invited to present at Danish Business Club Meeting organized by the Embassy of Denmark at Bio4Dreams site Regione Lombardia
Neuro-Zone will be glad to meet you:
- 5-7 November, Copenhagen, Denmark at BIO Europe 2018
- 4-7 June, Boston, US at BIO 2018
Highlights:
- June 2018: Neuro-Zone as consortium partner in NeOn, a project focused on the creation of an innovative R&D platform for the discovery and development of new treatments to counteract CNS diseases and cancer. Press Release | Regione Lombardia | Sole24Ore
- April 2018: Neuro-Zone launches MITOS Platform, Mitochondrial Integrity, Toxicity and Oxidative Stress, an analytical platform dedicated to the characterization of mitochondrial function and dysfunction.
Neuro-Zone will be glad to meet you:
- 6-8 November, Berlin, Germany at BIO Europe 2017
- 9-11 January, San Francisco, US at Biotech Showcase
- 19-22 June, San Diego, US at BIO 2017
- 11-13 January, San Francisco, US at Biotech Showcase
Highlights:
- January 2016: Neuro-Zone announces MicroTISSUE- The Multiparametric Microfluidic Platform for Phenotypic screening of the Extracellular Microenvironment.
- March 2016: Neuro-Zone launches new Neuropathic Pain Pathology Platform for screening and Drug Discovery, within the MicroTISSUE Platform Program.
- September 2016: Neuro-Zone launches new Cardiogenic Shock and Septic Shock Platform for screening and Drug Discovery, within the MicroTISSUE Platform Program.
Neuro-Zone will be glad to meet you:
- 2-4 November, Munich, Germany at BIO Europe 2015
- 15-18 June, Philadelphia, PA (US) at BIO International Convention 2015
- 7 May, Openzone – Bresso (MI) at Open Day Sanipedia
- 12-14 January, San Francisco, US at Biotech Showcase
Highlights:
Neuro-Zone will be glad to meet you:
- 3-5 November, Frankfurt, Germany at BIO Europe 2014
Neuro-Zone will be glad to meet you:
- 22-25 April November, Chicago, US at BIO International Convention 2013
- 3-5 October, Rome, Italy at SINS